Merck & Co. Inc. (MRK) Price Targets: What Do They Mean?

As of Thursday close, Merck & Co. Inc.’s (NYSE:MRK) stock was up $1.64, moving up 1.84 percent to $90.83. The average number of shares traded per day over the past five days has been 13,409,641 shares. 4 times new highs have been achieved over the past 5 days, with a $2.82 gain in that time frame. In the last twenty days, the average volume was 11,953,410, while in the previous 50 days, it was 11,296,420.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Since last month, MRK stock rose 6.07%. Shares of the company fell to $83.53 on 04/25/22, the lowest level in the past month. A 52-week high of $91.40 was reached on 05/12/22 after having rallying from a 52-week low of $70.89. Since the beginning of this year, MRK’s stock price has risen by 18.52% or $14.19, and marked a new high 18 times. However, the stock has declined by -0.62% since its 52-week high.

Merck & Co. Inc. (MRK) last reported insider trading activity 185 days ago on Nov 09. FRAZIER KENNETH C, the Executive Chair of the company, disposed of 663,881 shares for $82.26 on Nov 09. It resulted in a $54,611,362 divestment by the insider. Litchfield Caroline sold 18,335 shares at an average price of $91.00 on Nov 04. The insider now owns 24,114 shares following the transaction. On Nov 04, EVP&Pres, Merck Animal Heallth DeLuca Richard R. sold 29,782 shares at $90.40 apiece. The transaction was valued at $2,692,299.

Valuation Metrics

Right now, Merck & Co. Inc. (MRK) has a P/E ratio of about 16.56. The stock’s beta is 0.38. Besides these, the trailing price-to-sales (P/S) ratio of 4.24, the price-to-book (PB) ratio of 5.62, and the price-to-cash flow ratio of 37.66 may also be considered.

The latest dividend of $0.69 per share was paid out, remained unchanged from last year’s $0.69. On Tuesday November 30 2021, a $0.04 dividend increase was announced.

Financial Health

In the three months ended September 29, Merck & Co. Inc.’s quick ratio stood at 1.10, while its current ratio was 1.40, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.75, and the total debt-to-equity ratio was 0.78. On the profitability front, the trailing twelve-month gross margin is 72.40% percent. In the year ended September 29, operating margins totaled 28.90%. Based on annual data, MRK earned $35.08 billion in gross profit and brought in $48.7 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 15.50%. Return on equity (ROE) for the past 12 months was 38.30%.

In Merck & Co. Inc.’s quarter-end financial report for September 29, it reported total debt of $30.59 billion against cash and short-term investments of $372.0 million. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. MRK’s revenue rose 24.03% to $12.07 billion during the quarter, while net income inched up to $15.9 billion. While analysts expected Merck & Co. Inc. to report $1.55 quarterly earnings, the actual figure was $1.75 per share, beating the consensus estimate by 12.90%. During the quarter, the company generated $4.1 billion in EBITDA. The liabilities of Merck & Co. Inc. were 67.44 billion at the end of its most recent quarter ended September 29, and its total debt was $26.44 billion. The value of shareholders’ equity is $2.53 billion.

Technical Picture

This quick technical analysis looks at Merck & Co. Inc.’s (MRK) price momentum. With a historical volatility rate of 17.26%, the RSI 9-day stood at 71.70% on 12 May.

With respect to its five-day moving average, the current Merck & Co. Inc. price is up by +3.20% percent or $2.82. At present, MRK shares trade +5.46% above its 20-day simple moving average and +20.00% percent above its 100-day simple moving average. However, the stock is currently trading approximately +18.47% above its SMA50 and +15.96% above its SMA200.

Stochastic coefficient K was 81.17% and Stochastic coefficient D was 72.80%, while ATR was 2.13. Given the Stochastic reading of 99.73% for the 14-day period, the RSI (14) reading has been calculated as 68.72%. As of today, the MACD Oscillator reading stands at 0.93, while the 14-day reading stands at 1.65.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles